BACKGROUND: The mechanism underlying aortic dilatation is still unknown. Vascular dilatation is thought to be the result of progressive aortic media degeneration caused by defective vascular matrix hemostasis, including TGF-β1 dysregulation. The goal of this study is to draw attention to the potential utility of TGF-β1 as a diagnostic marker in non-syndromic patients with aortic dilatation. METHODS: TGF-β1 levels in plasma were measured in 50 patients who had undergone surgery and had a tricuspid or bicuspid aortic valve as well as a normal or dilated ascending aorta. A pathologist also examined thirty resected aorta samples. To specify the reference range of TGF-β1, a control group of 40 volunteers was enrolled in this study. RESULTS: We discovered a significant difference in TGF-β1 levels between patients with aortic dilatation and the control group (32.5 vs. 63.92; P < 0.001), as well as between patients with non-dilated aorta but with aortic valve disease, and the control group (27.68 vs. 63.92; P < 0.001). There was no difference between the dilated ascending aorta group and the non-dilated ascending aorta group. We found a poor correlation between TGF-β1 levels and ascending aorta diameter as well as the grade of ascending aorta histopathological abnormalities. CONCLUSION: TGF-β1 concentration does not meet the criteria to be a specific marker of aortic dilatation, but it is sensitive to aortic valvulopathy-aortopathy. A larger patient cohort study is needed to confirm these findings.

Department of Cardiac Surgery Faculty of Medicine University Hospital Hradec Králové Charles University Hradec Králové Czechia

Institute of Clinical Biochemistry and Diagnostics Faculty of Medicine in Hradec Králové University Hospital Hradec Králové Charles University Hradec Králové Czechia

The Fingerland Department of Pathology Faculty of Medicine in Hradec Králové University Hospital Hradec Králové Charles University Hradec Králové Czechia

Zobrazit více v PubMed

Hiratzka LF, Bakris GL, Beckman JA, Bersin RM, Carr VF, Casey DE, Jr., et al. 2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM guidelines for the diagnosis and management of patients with thoracic aortic disease: a report of the American college of cardiology foundation/American heart association task force on practice guidelines, American association for thoracic surgery, American college of radiology, American stroke association, society of cardiovascular anesthesiologists, society for cardiovascular angiography and interventions, society of interventional radiology, society of thoracic surgeons, and society for vascular medicine. Circulation. (2010) 121:e266–369. PubMed

Gillis E, Van Laer L, Loeys BL. Genetics of thoracic aortic aneurysm: at the crossroad of transforming growth factor-beta signaling and vascular smooth muscle cell contractility. Circ Res. (2013) 113:327–40. 10.1161/CIRCRESAHA.113.300675 PubMed DOI

Losenno KL, Goodman RL, Chu MW. Bicuspid aortic valve disease and ascending aortic aneurysms: gaps in knowledge. Cardiol Res Pract. (2012) 2012:145202. PubMed PMC

Prakash SK, Bossé Y, Muehlschlegel JD, Michelena HI, Limongelli G, Della Corte A, et al. A roadmap to investigate the genetic basis of bicuspid aortic valve and its complications: insights from the international BAVCon (bicuspid aortic valve consortium). J Am Coll Cardiol. (2014) 64:832–9. 10.1016/j.jacc.2014.04.073 PubMed DOI PMC

Verma S, Siu SC. Aortic dilatation in patients with bicuspid aortic valve. N Engl J Med. (2014) 370:1920–9. PubMed

Sepetiene R, Patamsyte V, Zukovas G, Jariene G, Stanioniene Z, Benetis R, et al. Blood plasma TGF- beta1 concentration in sporadic dilatative pathology of ascending aorta: more questions than answers. PLoS One. (2015) 10:e0129353. 10.1371/journal.pone.0129353 PubMed DOI PMC

Annes JP, Munger JS, Rifkin DB. Making sense of latent TGFbeta activation. J Cell Sci. (2003) 116:217–24. 10.1242/jcs.00229 PubMed DOI

Lindsay ME, Dietz HC. Lessons on the pathogenesis of aneurysm from heritable conditions. Nature. (2011) 473:308–16. 10.1038/nature10145 PubMed DOI PMC

Jain D, Dietz HC, Oswald GL, Maleszewski JJ, Halushka MK. Causes and histopathology of ascending aortic disease in children and young adults. Cardiovasc Pathol. (2011) 20:15–25. 10.1016/j.carpath.2009.09.008 PubMed DOI PMC

Halushka MK, Angelini A, Bartoloni G, Basso C, Batoroeva L, Bruneval P, et al. Consensus statement on surgical pathology of the aorta from the society for cardiovascular pathology and the association for European cardiovascular pathology: II. Noninflammatory degenerative diseases – nomenclature and diagnostic criteria. Cardiovasc Pathol. (2016) 25:247–57. 10.1016/j.carpath.2016.03.002 PubMed DOI

He R, Guo DC, Estrera AL, Safi HJ, Huynh TT, Yin Z, et al. Characterization of the inflammatory and apoptotic cells in the aortas of patients with ascending thoracic aortic aneurysms and dissections. J Thorac Cardiovasc Surg. (2006) 131:671–8. 10.1016/j.jtcvs.2005.09.018 PubMed DOI

Schmid FX, Bielenberg K, Schneider A, Haussler A, Keyser A, Birnbaum D. Ascending aortic aneurysm associated with bicuspid and tricuspid aortic valve: involvement and clinical relevance of smooth muscle cell apoptosis and expression of cell death-initiating proteins. Eur J Cardiothorac Surg. (2003) 23:537–43. 10.1016/s1010-7940(02)00833-3 PubMed DOI

Wortmann M, Skorubskaya E, Peters AS, Hakimi M, Böckler D, Dihlmann S. Necrotic cell debris induces a NF-kappaB-driven inflammasome response in vascular smooth muscle cells derived from abdominal aortic aneurysms (AAA-SMC). Biochem Biophys Res Commun. (2019) 511:343–9. 10.1016/j.bbrc.2019.02.051 PubMed DOI

Munger JS, Harpel JG, Giancotti FG, Rifkin DB. Interactions between growth factors and integrins: latent forms of transforming growth factor-beta are ligands for the integrin alphavbeta1. Mol Biol Cell. (1998) 9:2627–38. 10.1091/mbc.9.9.2627 PubMed DOI PMC

Munger JS, Harpel JG, Gleizes PE, Mazzieri R, Nunes I, Rifkin DB, et al. Latent transforming growth factor-beta: structural features and mechanisms of activation. Kidney Int. (1997) 51:1376–82. PubMed

Vahanian A, Beyersdorf F, Praz F, Milojevic M, Baldus S, Bauersachs J, et al. 2021 ESC/EACTS guidelines for the management of valvular heart disease. Eur Heart J. (2022) 43:561–632. PubMed

Larson EW, Edwards WD. Risk factors for aortic dissection: a necropsy study of 161 cases. Am J Cardiol. (1984) 53:849–55. 10.1016/0002-9149(84)90418-1 PubMed DOI

Forte A, Bancone C, Cobellis G, Buonocore M, Santarpino G, Fischlein TJM, et al. A possible early biomarker for bicuspid aortopathy: circulating transforming growth factor beta-1 to soluble endoglin ratio. Circ Res. (2017) 120:1800–11. 10.1161/CIRCRESAHA.117.310833 PubMed DOI

Gomez D, Al Haj Zen A, Borges LF, Philippe M, Gutierrez PS, Jondeau G, et al. Syndromic and non-syndromic aneurysms of the human ascending aorta share activation of the Smad2 pathway. J Pathol. (2009) 218:131–42. 10.1002/path.2516 PubMed DOI

Skotsimara G, Antonopoulos A, Oikonomou E, Papastamos C, Siasos G, Tousoulis D. Aortic wall inflammation in the pathogenesis, diagnosis and treatment of aortic aneurysms. Inflammation. (2022) 45:965–76. PubMed

Juvonen J, Surcel HM, Satta J, Teppo AM, Bloigu A, Syrjälä H, et al. Elevated circulating levels of inflammatory cytokines in patients with abdominal aortic aneurysm. Arterioscler Thromb Vasc Biol. (1997) 17:2843–7. PubMed

Batra R, Suh MK, Carson JS, Dale MA, Meisinger TM, Fitzgerald M, et al. IL-1β (Interleukin-1β) and TNF-α (tumor necrosis factor-α) impact abdominal aortic aneurysm formation by differential effects on macrophage polarization. Arterioscler Thromb Vasc Biol (2018) 38:457–63. PubMed PMC

Yuan SH, Shi YH, Wang JJ, Lü FQ, Gao S. Elevated plasma D-dimer and hypersensitive C-reactive protein levels may indicate aortic disorders. Rev Bras Cir Cardiovasc. (2011) 26:573–81. 10.5935/1678-9741.20110047 PubMed DOI

Ikonomidis JS, Ivey CR, Wheeler JB, Akerman AW, Rice A, Patel RK, et al. Plasma biomarkers for distinguishing etiologic subtypes of thoracic aortic aneurysm disease. J Thorac Cardiovasc Surg. (2013) 145:1326–33. 10.1016/j.jtcvs.2012.12.027 PubMed DOI PMC

Siasos G, Bletsa E, Stampouloglou PK, Oikonomou E, Tsigkou V, Paschou SA, et al. MicroRNAs in cardiovascular disease. Hellenic J Cardiol. (2020) 61:165–73. PubMed

Gomez D, Kessler K, Michel JB, Vranckx R. Modifications of chromatin dynamics control Smad2 pathway activation in aneurysmal smooth muscle cells. Circ Res. (2013) 113:881–90. 10.1161/CIRCRESAHA.113.301989 PubMed DOI

Hillebrand M, Millot N, Sheikhzadeh S, Rybczynski M, Gerth S, Kölbel T, et al. Total serum transforming growth factor-beta1 is elevated in the entire spectrum of genetic aortic syndromes. Clin Cardiol. (2014) 37:672–9. 10.1002/clc.22320 PubMed DOI PMC

Wheeler JB, Ikonomidis JS, Jones JA. Connective tissue disorders and cardiovascular complications: the indomitable role of transforming growth factor-β signaling. Adv Exp Med Biol. (2021) 1348:161–84. PubMed PMC

Matt P, Schoenhoff F, Habashi J, Holm T, Van Erp C, Loch D, et al. Circulating transforming growth factor-beta in Marfan syndrome. Circulation. (2009) 120:526–32. PubMed PMC

Rueda-Martinez C, Lamas O, Carrasco-Chinchilla F, Robledo-Carmona J, Porras C. Increased blood levels of transforming growth factor beta in patients with aortic dilatation. Interact Cardiovasc Thorac Surg. (2017) 25:571–4. PubMed

Ausoni S, Sartore S. Cell lineages and tissue boundaries in cardiac arterial and venous poles: developmental patterns, animal models, and implications for congenital vascular diseases. Arterioscler Thromb Vasc Biol. (2001) 21:312–20. 10.1161/01.atv.21.3.312 PubMed DOI

Kappetein AP, Gittenberger-de Groot AC, Zwinderman AH, Rohmer J, Poelmann RE, Huysmans HA. The neural crest as a possible pathogenetic factor in coarctation of the aorta and bicuspid aortic valve. J Thorac Cardiovasc Surg. (1991) 102:830–6. PubMed

Kirby ML, Waldo KL. Role of neural crest in congenital heart disease. Circulation. (1990) 82:332–40. PubMed

Morrison-Graham K, Schatteman GC, Bork T, Bowen-Pope DF, Weston JA. A PDGF receptor mutation in the mouse (Patch) perturbs the development of a non-neuronal subset of neural crest-derived cells. Development. (1992) 115:133–42. 10.1242/dev.115.1.133 PubMed DOI

Ser OS, Çetinkal G, Kiliçarslan O, Dalgıç Y, Batit S, Keskin K, et al. The comparison of serum TGF-beta levels and associated polymorphisms in patients with coronary artery ectasia and normal coronary artery. Egypt Heart J. (2021) 73:32. 10.1186/s43044-021-00153-w PubMed DOI PMC